Exelixis
EXEL
#1773
Rank
NZ$16.79 B
Marketcap
$58.80
Share price
0.67%
Change (1 day)
66.14%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company